SPONSOR
NOUR ALI ABO EL ELAA FRAGHLY
Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Lateral Epicondylitis
NOUR ALI ABO EL ELAA FRAGHLY is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Lateral Epicondylitis.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — NOUR ALI ABO EL ELAA FRAGHLY
How many clinical trials has NOUR ALI ABO EL ELAA FRAGHLY sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by NOUR ALI ABO EL ELAA FRAGHLY, of which 1 are actively recruiting participants. These trials cover conditions including Lateral Epicondylitis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does NOUR ALI ABO EL ELAA FRAGHLY research focus on?
NOUR ALI ABO EL ELAA FRAGHLY clinical trials span Lateral Epicondylitis. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a NOUR ALI ABO EL ELAA FRAGHLY clinical trial?
To participate in a NOUR ALI ABO EL ELAA FRAGHLY trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all NOUR ALI ABO EL ELAA FRAGHLY trials with current recruitment status updated daily.
Clinical Trials by NOUR ALI ABO EL ELAA FRAGHLY
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology